HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michael H Ossipov Selected Research

dibutyldichlorotin

11/2010Attenuation of persistent experimental pancreatitis pain by a bradykinin b2 receptor antagonist.
11/2010Reversal of pancreatitis-induced pain by an orally available, small molecule interleukin-6 receptor antagonist.
10/2008Reversal of inflammatory and noninflammatory visceral pain by central or peripheral actions of sumatriptan.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michael H Ossipov Research Topics

Disease

45Pain (Aches)
06/2020 - 01/2002
26Hypersensitivity (Allergy)
03/2014 - 06/2002
22Hyperalgesia
07/2012 - 06/2004
18Neuralgia (Stump Neuralgia)
01/2018 - 01/2002
13Chronic Pain
01/2017 - 01/2005
12Migraine Disorders (Migraine)
06/2020 - 02/2009
6Inflammation (Inflammations)
11/2010 - 10/2008
4Headache (Headaches)
08/2013 - 10/2008
3Neoplasms (Cancer)
02/2019 - 01/2005
3Secondary Headache Disorders
02/2011 - 03/2010
3Pancreatitis
11/2010 - 06/2006
3Peripheral Nerve Injuries
02/2010 - 06/2004
2Postoperative Pain
01/2017 - 12/2012
2Major Depressive Disorder (Major Depressive Disorders)
01/2017 - 03/2016
2Crush Injuries
03/2014 - 04/2008
2Nervous System Diseases (Neurological Disorders)
05/2013 - 08/2010
2Visceral Pain
10/2010 - 10/2008
2Vomiting
05/2009 - 01/2005
2Nausea
05/2009 - 01/2005
1Injection Site Reaction
01/2018
1Erythema
01/2018
1Pruritus (Itching)
01/2018
1Low Back Pain (Lumbago)
01/2017
1Nociceptive Pain
01/2017
1Osteoarthritis
01/2017
1Mental Disorders (Mental Disorder)
01/2017
1Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
01/2017
1Neurogenic Inflammation
01/2017

Drug/Important Bio-Agent (IBA)

23Opioid Analgesics (Opioids)IBA
01/2018 - 08/2002
13Morphine (MS Contin)FDA LinkGeneric
01/2017 - 08/2002
13Dynorphins (Dynorphin)IBA
11/2010 - 06/2002
11Analgesics (Analgesic Drugs)IBA
01/2017 - 06/2003
10Opiate AlkaloidsIBA
01/2017 - 01/2005
10Lidocaine (Xylocaine)FDA LinkGeneric
08/2013 - 06/2002
6Tryptamines (Triptans)IBA
06/2020 - 10/2008
5Calcitonin Gene-Related PeptideIBA
06/2020 - 02/2009
4Ondansetron (Zofran)FDA LinkGeneric
08/2013 - 05/2007
4Sumatriptan (Imigran)FDA LinkGeneric
08/2013 - 10/2008
4Cholecystokinin B ReceptorIBA
08/2013 - 01/2005
4Cholecystokinin Receptors (Cholecystokinin Receptor)IBA
06/2011 - 01/2005
3Serotonin (5 Hydroxytryptamine)IBA
06/2020 - 08/2013
3Neurotransmitter Agents (Neurotransmitter)IBA
06/2020 - 12/2005
3NeuropeptidesIBA
06/2020 - 01/2005
3Nerve Growth Factor (NGF)IBA
01/2017 - 06/2011
3Duloxetine Hydrochloride (Cymbalta)FDA Link
01/2017 - 03/2014
3Proteins (Proteins, Gene)FDA Link
09/2014 - 08/2007
3Opioid Receptors (Opioid Receptor)IBA
06/2011 - 06/2004
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
06/2011 - 01/2005
3dibutyldichlorotinIBA
11/2010 - 10/2008
3Cholecystokinin (Pancreozymin)IBA
03/2009 - 01/2005
3dermorphin-saporinIBA
03/2009 - 06/2002
2lasmiditanIBA
06/2020 - 01/2020
2Monoclonal AntibodiesIBA
01/2018 - 01/2017
26-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA
08/2014 - 08/2013
2Dopamine (Intropin)FDA LinkGeneric
08/2014 - 12/2012
2ElementsIBA
06/2014 - 06/2011
2Norepinephrine (Noradrenaline)FDA LinkGeneric
06/2014 - 03/2014
2salicylhydroxamic acid (SHAM)IBA
03/2014 - 09/2003
2Local AnestheticsIBA
12/2012 - 06/2004
2Substance PIBA
07/2012 - 10/2010
2Iodoacetic AcidIBA
04/2012 - 04/2011
2LigandsIBA
06/2011 - 01/2005
2Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA
06/2011 - 01/2005
2Clonidine (ST 155)FDA LinkGeneric
04/2011 - 06/2004
2Proteasome InhibitorsIBA
07/2010 - 08/2007
2Proteasome Endopeptidase Complex (Proteasome)IBA
07/2010 - 08/2007
2SaporinsIBA
03/2009 - 05/2007
2mu Opioid Receptors (mu Opioid Receptor)IBA
03/2009 - 06/2002
2Bradykinin Receptors (Bradykinin Receptor)IBA
12/2008 - 12/2006
2BradykininIBA
12/2008 - 12/2006
2Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA
05/2007 - 08/2005
2L-Type Calcium Channels (Dihydropyridine Receptor)IBA
12/2005 - 09/2003
2Sodium Channels (Sodium Channel)IBA
10/2005 - 01/2002
2Ion Channels (Ion Channel)IBA
10/2005 - 06/2004
2Dizocilpine Maleate (Dizocilpine)IBA
06/2004 - 11/2002
1Blood Proteins (Serum Proteins)IBA
06/2020
1Glutamic Acid (Glutamate)FDA Link
06/2020
1Serotonin Receptor Agonists (Serotonin Receptor Agonist)IBA
06/2020
1DNA (Deoxyribonucleic Acid)IBA
02/2019
1galcanezumabIBA
01/2018
1Ethanol (Ethyl Alcohol)IBA
01/2017
1Cocaine (Cocaine HCl)IBA
01/2017
1Cannabinoid Receptors (Cannabinoid Receptor)IBA
01/2017
1CB2 Cannabinoid ReceptorIBA
01/2017
1Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric
01/2017
1NicotineFDA Link
01/2017
1Naproxen (Naprosyn)FDA LinkGeneric
08/2014
1Biomarkers (Surrogate Marker)IBA
08/2014
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
08/2014
1KetorolacIBA
08/2014
1Gabapentin (Neurontin)FDA LinkGeneric
08/2014

Therapy/Procedure

21Therapeutics
06/2020 - 06/2002
9Ligation
01/2018 - 06/2002
4Spinal Injections
04/2011 - 06/2004
3Analgesia
01/2017 - 05/2009
1Subcutaneous Injections
01/2018
1Orthopedic Procedures
01/2017
1Hip Replacement Arthroplasty (Total Hip Replacement)
01/2017
1Knee Replacement Arthroplasty (Total Knee Replacement)
01/2017
1Physical Therapy Modalities (Physical Therapy Technique)
01/2017